| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
36,539 |
31,331 |
$2.05M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
28,642 |
25,605 |
$1.99M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14,795 |
11,884 |
$1.71M |
| 80053 |
Comprehensive metabolic panel |
27,195 |
22,489 |
$685K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,396 |
7,979 |
$494K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,187 |
5,469 |
$409K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,121 |
4,574 |
$388K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,448 |
4,124 |
$362K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,919 |
4,383 |
$307K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13,783 |
11,065 |
$294K |
| 59025 |
Fetal non-stress test |
3,654 |
2,570 |
$282K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
5,132 |
3,960 |
$260K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,130 |
2,822 |
$248K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,208 |
3,340 |
$239K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
704 |
625 |
$221K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,884 |
5,163 |
$217K |
| 76801 |
|
3,230 |
2,883 |
$199K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,532 |
2,348 |
$193K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,662 |
26,230 |
$187K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,709 |
2,417 |
$171K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,446 |
2,868 |
$157K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,500 |
1,381 |
$149K |
| G0378 |
Hospital observation service, per hour |
5,469 |
4,217 |
$143K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,755 |
1,592 |
$142K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,880 |
2,491 |
$125K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,571 |
1,408 |
$116K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,307 |
828 |
$109K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
2,155 |
932 |
$108K |
| 81025 |
|
10,688 |
9,417 |
$106K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,046 |
2,779 |
$101K |
| 90791 |
Psychiatric diagnostic evaluation |
2,763 |
2,378 |
$101K |
| 84484 |
|
12,559 |
8,485 |
$101K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,079 |
2,801 |
$96K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,317 |
1,188 |
$94K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,729 |
2,401 |
$84K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,540 |
2,257 |
$75K |
| 82962 |
|
12,696 |
5,708 |
$74K |
| 83880 |
|
3,245 |
2,827 |
$68K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
820 |
759 |
$65K |
| 83605 |
|
8,339 |
6,184 |
$62K |
| 80306 |
|
3,952 |
3,478 |
$61K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
624 |
575 |
$60K |
| 81001 |
|
11,898 |
10,402 |
$58K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,559 |
2,389 |
$57K |
| 93975 |
|
1,202 |
1,094 |
$56K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,666 |
4,097 |
$55K |
| 93296 |
|
2,428 |
2,244 |
$51K |
| 83690 |
|
9,636 |
8,308 |
$50K |
| 84702 |
|
1,432 |
1,226 |
$49K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,485 |
1,976 |
$47K |
| 87808 |
|
2,550 |
2,239 |
$44K |
| 82077 |
|
4,511 |
3,759 |
$44K |
| 85027 |
|
8,218 |
6,458 |
$42K |
| 76813 |
|
2,027 |
1,871 |
$42K |
| 80143 |
|
2,601 |
2,195 |
$41K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
800 |
661 |
$40K |
| 81003 |
|
6,814 |
6,110 |
$35K |
| 87205 |
|
3,955 |
3,225 |
$35K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,080 |
797 |
$33K |
| 82805 |
|
1,156 |
952 |
$30K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
411 |
367 |
$27K |
| 86850 |
|
3,627 |
3,119 |
$26K |
| 84145 |
|
1,705 |
1,405 |
$26K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
668 |
599 |
$26K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
409 |
357 |
$24K |
| 80179 |
|
2,492 |
2,134 |
$24K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
567 |
340 |
$23K |
| 87081 |
|
1,280 |
1,207 |
$23K |
| 83735 |
|
5,057 |
3,997 |
$22K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
454 |
410 |
$22K |
| 87077 |
|
2,409 |
1,862 |
$22K |
| 87040 |
|
3,033 |
1,420 |
$21K |
| 93458 |
|
62 |
52 |
$20K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,316 |
2,082 |
$20K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,044 |
920 |
$20K |
| 12001 |
|
220 |
199 |
$19K |
| 87486 |
|
394 |
342 |
$18K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
172 |
151 |
$17K |
| 70498 |
|
192 |
176 |
$17K |
| 85379 |
|
2,098 |
1,922 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,094 |
1,863 |
$16K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
816 |
497 |
$15K |
| 87186 |
|
1,997 |
1,608 |
$15K |
| G0379 |
Direct admission of patient for hospital observation care |
469 |
407 |
$15K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
620 |
564 |
$14K |
| 70496 |
|
145 |
132 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
22,521 |
18,672 |
$12K |
| 93971 |
|
322 |
300 |
$12K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,664 |
1,469 |
$12K |
| 87631 |
|
78 |
78 |
$12K |
| 85610 |
|
4,533 |
3,577 |
$12K |
| 87581 |
|
394 |
342 |
$11K |
| 76830 |
Ultrasound, transvaginal |
345 |
304 |
$11K |
| 80050 |
General health panel |
1,760 |
1,590 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
8,912 |
7,782 |
$9K |
| 80061 |
Lipid panel |
1,409 |
1,260 |
$9K |
| 86900 |
|
3,719 |
3,196 |
$9K |
| 87070 |
|
866 |
655 |
$9K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,363 |
3,243 |
$9K |
| 86901 |
|
3,752 |
3,232 |
$9K |
| 78431 |
|
46 |
40 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
6,912 |
6,235 |
$7K |
| 84703 |
|
722 |
654 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,907 |
14,354 |
$6K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
395 |
309 |
$5K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
13 |
12 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
343 |
309 |
$5K |
| 12011 |
|
46 |
44 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,460 |
9,297 |
$5K |
| 87653 |
|
114 |
108 |
$5K |
| 97162 |
|
193 |
167 |
$5K |
| 70486 |
|
175 |
164 |
$5K |
| 90715 |
|
552 |
509 |
$4K |
| 86140 |
|
1,019 |
889 |
$3K |
| 12002 |
|
39 |
37 |
$3K |
| 76820 |
|
43 |
15 |
$2K |
| 29125 |
|
52 |
50 |
$2K |
| 85730 |
|
436 |
357 |
$2K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
157 |
147 |
$2K |
| 93798 |
|
72 |
12 |
$2K |
| 80047 |
|
46 |
40 |
$2K |
| 64400 |
|
13 |
12 |
$2K |
| 96367 |
|
38 |
26 |
$2K |
| 84112 |
|
19 |
13 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,497 |
1,247 |
$2K |
| 80305 |
|
35 |
34 |
$2K |
| 93325 |
|
71 |
66 |
$1K |
| 93017 |
|
56 |
51 |
$1K |
| 88342 |
|
1,113 |
892 |
$1K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
40 |
39 |
$1K |
| 97166 |
|
41 |
38 |
$1K |
| 51798 |
|
695 |
533 |
$1K |
| 82550 |
|
214 |
186 |
$1K |
| P9045 |
Infusion, albumin (human), 5%, 250 ml |
17 |
12 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,056 |
5,436 |
$1K |
| 10060 |
|
16 |
14 |
$987.53 |
| 73030 |
|
616 |
537 |
$905.14 |
| 82570 |
|
306 |
257 |
$900.46 |
| 86803 |
|
18 |
18 |
$890.80 |
| 97161 |
|
13 |
12 |
$630.87 |
| 73610 |
|
925 |
851 |
$591.85 |
| 85014 |
|
361 |
303 |
$566.79 |
| 87075 |
|
113 |
63 |
$521.90 |
| 72100 |
|
271 |
247 |
$478.13 |
| 73562 |
|
1,131 |
985 |
$463.65 |
| 88307 |
|
240 |
169 |
$449.22 |
| 82565 |
|
16 |
14 |
$373.80 |
| 97116 |
|
17 |
12 |
$346.39 |
| 76937 |
|
44 |
40 |
$343.08 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
25,912 |
19,904 |
$338.87 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
9,837 |
7,925 |
$314.09 |
| 85018 |
|
186 |
139 |
$292.58 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
628 |
572 |
$259.18 |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,124 |
1,910 |
$250.68 |
| 85652 |
|
134 |
114 |
$230.67 |
| 84100 |
|
67 |
38 |
$230.37 |
| 96376 |
|
3,803 |
2,708 |
$205.66 |
| 87340 |
|
29 |
25 |
$194.13 |
| 93298 |
|
16 |
14 |
$187.20 |
| 73630 |
|
812 |
747 |
$186.28 |
| 99292 |
|
19 |
14 |
$168.98 |
| J2704 |
Injection, propofol, 10 mg |
6,517 |
5,084 |
$166.60 |
| 72170 |
|
298 |
266 |
$147.70 |
| 36415 |
Collection of venous blood by venipuncture |
8,109 |
5,307 |
$145.04 |
| 84156 |
|
46 |
40 |
$140.96 |
| 87147 |
|
26 |
25 |
$131.47 |
| 86780 |
|
13 |
12 |
$114.16 |
| 84466 |
|
41 |
36 |
$94.38 |
| 84439 |
|
20 |
12 |
$93.20 |
| 73130 |
|
679 |
596 |
$83.61 |
| 74018 |
|
98 |
87 |
$82.98 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,523 |
9,433 |
$74.23 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
10,472 |
8,690 |
$73.33 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
7,875 |
5,987 |
$69.07 |
| 86592 |
|
16 |
15 |
$61.74 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
30 |
26 |
$60.19 |
| 83540 |
|
42 |
37 |
$49.17 |
| 73110 |
|
275 |
242 |
$46.54 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,932 |
11,131 |
$44.62 |
| 0352U |
|
155 |
141 |
$30.42 |
| 82607 |
|
12 |
12 |
$21.62 |
| 82272 |
|
12 |
12 |
$21.30 |
| 85007 |
|
33 |
30 |
$18.90 |
| 73502 |
|
25 |
25 |
$18.47 |
| 88304 |
|
66 |
49 |
$17.54 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,688 |
2,162 |
$15.33 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,765 |
5,657 |
$15.26 |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,113 |
3,429 |
$13.99 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,931 |
2,620 |
$13.46 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
7,880 |
5,287 |
$13.12 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,190 |
5,060 |
$12.38 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,117 |
1,812 |
$12.22 |
| 82043 |
|
16 |
16 |
$11.60 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,381 |
1,040 |
$11.35 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,184 |
3,510 |
$7.09 |
| C1769 |
Guide wire |
919 |
771 |
$3.30 |
| J1630 |
Injection, haloperidol, up to 5 mg |
64 |
50 |
$3.06 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,066 |
1,351 |
$1.44 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
654 |
496 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,231 |
996 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
523 |
385 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
450 |
327 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
94 |
77 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
32 |
27 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
316 |
259 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
13 |
13 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
102 |
91 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
140 |
65 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
97 |
69 |
$0.00 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
16 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
97 |
57 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
58 |
50 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
53 |
48 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
30 |
27 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
53 |
40 |
$0.00 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
15 |
13 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
16 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
13 |
13 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
2,467 |
2,049 |
$0.00 |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
46 |
40 |
$0.00 |
| A9270 |
Non-covered item or service |
6,740 |
4,214 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
12 |
12 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
391 |
340 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
394 |
329 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
765 |
567 |
$0.00 |
| 88341 |
|
191 |
96 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
443 |
343 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
15 |
13 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
120 |
104 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
73 |
70 |
$0.00 |
| J3490 |
Unclassified drugs |
71 |
65 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
44 |
38 |
$0.00 |
| 74019 |
|
13 |
12 |
$0.00 |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
13 |
13 |
$0.00 |
| 71101 |
|
14 |
12 |
$0.00 |